ArticleScientific reports2019

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.

Sabine Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.